Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Advances in Therapy|December 16, 2024
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare AnalysisJagadeswara R Earla, Allison W Kurian, Kalé Kponee-Shovein, et al.
Annals of Surgical Oncology|January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast CancerHatem Soliman, Susanne Wagner, Darl D Flake, et al.
Cold Spring Harbor Molecular Case Studies|June 29, 2017
Germline <i>BRCA2</i> mutations detected in pediatric sequencing studies impact parents' evaluation and careMichael F Walsh, Jennifer Kennedy, Megan Harlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2Deborah Goldfrank, Shannon Chuai, Jonine L Bernstein, et al.
BMC Medical Genetics|January 17, 2003
Frequency of CHEK2*1100delC in New York breast cancer cases and controlsKenneth Offit, Heather Pierce, Tomas Kirchhoff, et al.
Cancer Medicine|June 23, 2021
Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancerN Ari Wijetunga, Carlos H Dos Anjos, W Iris Zhi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumorsCristina R Antonescu, Gunhild Sommer, Lisa Sarran, et al.
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 31, 2026
Consideration of inherited cancer risk on a continuum: An international and multidisciplinary perspective: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Joseph Christopher, Esteban Astiazaran-Symonds, et al.
JNCI Cancer Spectrum|November 23, 2020
Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled TrialTing Bao, Iris Zhi, Raymond Baser, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Advances in Therapy|December 16, 2024
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare AnalysisJagadeswara R Earla, Allison W Kurian, Kalé Kponee-Shovein, et al.
Annals of Surgical Oncology|January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast CancerHatem Soliman, Susanne Wagner, Darl D Flake, et al.
Cold Spring Harbor Molecular Case Studies|June 29, 2017
Germline <i>BRCA2</i> mutations detected in pediatric sequencing studies impact parents' evaluation and careMichael F Walsh, Jennifer Kennedy, Megan Harlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2Deborah Goldfrank, Shannon Chuai, Jonine L Bernstein, et al.
BMC Medical Genetics|January 17, 2003
Frequency of CHEK2*1100delC in New York breast cancer cases and controlsKenneth Offit, Heather Pierce, Tomas Kirchhoff, et al.
Cancer Medicine|June 23, 2021
Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancerN Ari Wijetunga, Carlos H Dos Anjos, W Iris Zhi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumorsCristina R Antonescu, Gunhild Sommer, Lisa Sarran, et al.
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 31, 2026
Consideration of inherited cancer risk on a continuum: An international and multidisciplinary perspective: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Joseph Christopher, Esteban Astiazaran-Symonds, et al.
JNCI Cancer Spectrum|November 23, 2020
Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled TrialTing Bao, Iris Zhi, Raymond Baser, et al.
Pageof 22